Form 4: Medpace CEO Sells Shares Under Pre-Arranged Plan

Medpace Holdings CEO August J. Troendle reported the sale of 10,440 shares of common stock over two days in November 2025.

Summary

• August J. Troendle, CEO, Director, and 10% Owner of Medpace Holdings, Inc. (MEDP), reported sales of common stock.
• On November 12, 2025, 5,312 shares were sold at a weighted average price of $603.23 per share.
• On November 13, 2025, an additional 5,128 shares were sold at a weighted average price of $601.37 per share.
• These transactions were executed pursuant to a limit order placed by the Reporting Person during an open window period, consistent with a Rule 10b5-1 plan.
• Following these sales, direct beneficial ownership stands at 914,162 shares.
• Indirect beneficial ownership through Medpace Investors, LLC remains at 4,733,019 shares, for which the Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral. This is a routine disclosure of an insider stock sale, which is a factual transaction and does not inherently convey positive or negative sentiment about the company's performance or future prospects. The sales were made pursuant to a pre-arranged plan (Rule 10b5-1).

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Awareness of insider selling activity by a key executive and 10% owner, which may influence market perception, despite being pre-planned.

Key Dates

Recommendation

The filing reports routine insider selling by the CEO and 10% owner, August J. Troendle, pursuant to a pre-arranged Rule 10b5-1 plan. While insider selling can sometimes be a negative signal, these transactions are often part of personal financial planning or diversification strategies and do not necessarily reflect a change in the company's fundamental outlook. Without additional context on the company's financial performance, valuation, or market conditions, a 'hold' recommendation is appropriate, as this filing alone does not provide sufficient grounds for a significant change in investment strategy.

Keywords

Medpace Holdings, MEDP, August J. Troendle, Insider Sale, Form 4, CEO, Director, 10% Owner, Stock Transaction, Rule 10b5-1